An Act Requiring Insurance Coverage For Scalp Cooling.
Summary
SB 88 requires certain health insurance policies in Connecticut to cover scalp cooling systems when those policies already cover chemotherapy. Scalp cooling systems are devices used during chemotherapy to cool the scalp and reduce hair loss. The bill applies to both individual and group health insurance policies of the types listed in the insurance statutes, and it would take effect January 1, 2027.
Under the bill, coverage for scalp cooling must be at least equivalent to the coverage provided under Medicare. The bill also limits cost-sharing by prohibiting insurers from imposing coinsurance, copayments, deductibles, or other out-of-pocket costs that are more restrictive than those applied to substantially all other covered benefits, with an exception for high-deductible health plans. Insurers may still require prior authorization, but only if they apply it in the same manner and to the same extent as for other covered benefits.
Impact
The bill would add a new mandated health insurance benefit in Connecticut law for chemotherapy-related scalp cooling systems, affecting both individual and group policies issued, renewed, amended, or continued on or after January 1, 2027. It would require insurers to align coverage with Medicare-level benefits and limit patient cost-sharing, while preserving insurers’ ability to use prior authorization under existing plan rules. The practical effect would be to expand access to a supportive cancer-treatment service and impose new coverage obligations on health carriers and health benefit plans.
Sentiment
The available context suggests generally favorable treatment of the bill, as it is presented as part of the Governor’s budget recommendations and there are no recorded committee transcripts or votes showing opposition or debate. The bill’s purpose is framed as a policy implementation measure rather than a controversial overhaul, which suggests it may be viewed as a targeted health coverage expansion. Because no voting history or hearing record is provided, there is no documented public sentiment beyond the bill’s introduction and stated purpose.
Contention
The main potential points of contention are likely to be the cost of a new mandated benefit for insurers and employers, the requirement that coverage be at least equivalent to Medicare, and the limits on patient cost-sharing. Insurers or plan sponsors could also focus on the administrative burden of prior authorization and the exception for high-deductible health plans. However, no specific objections, amendments, or opposing viewpoints are included in the provided record.